Citigroup
NRX

Citigroup’s NEPHROGENEX INC COM NRX Stock Holding History

Citigroup’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-101
Closed – – 8161
2015
Q3 		$0 Sell
101
-21
-17% -$92 ﹤0.01% 8122
2015
Q2 		$1K Sell
122
-90
-42% -$684 ﹤0.01% 7439
2015
Q1 		$2K Buy
212
+64
+43% +$502 ﹤0.01% 6992
2014
Q4 		$2K Buy
148
+86
+139% +$398 ﹤0.01% 6911
2014
Q3 		$0 Buy
+62
New +$295 ﹤0.01% 7497
2014
Q2 		– Sell
-174
Closed -$1K – 7499
2014
Q1 		$1K Buy
+174
New +$1.77K ﹤0.01% 6932

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup's NRX Position: Q4 2015 in Review

Citigroup sold out of NEPHROGENEX INC COM (NRX) in Q4 2015, closing a stake of 101 shares.

Citigroup first reported a position in NRX in Q1 2014 and held it in 6 quarters. The position peaked at $2K in Q1 2015. 15 funds tracked by Wall St. Rank hold NRX as of Q4 2015.

  • Citigroup reported no remaining NEPHROGENEX INC COM position as of Q4 2015 after selling out during the quarter.
  • Citigroup sold 101 NEPHROGENEX INC COM shares in Q4 2015.
  • Citigroup first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 6 quarters.
  • Citigroup's NEPHROGENEX INC COM position peaked at $2K in Q1 2015.
  • 15 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.